Probiotics in neurodegenerative disorders

Background:Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS), are associated with chronic neuroinflammation and gut microbiota dysbiosis. Increasing evidence suggests that modulation of the microbiota–gut–brain axis with probiotics may represent a novel therapeutic strategy. Aim:To summarize current evidence on the effects of probiotic supplementation in AD, PD, MS, and ALS, focusing on potential mechanisms of action and therapeutic outcomes. Material and methods: A review of scientific literature concerning the influence of gut microbiota on the nervous system through the microbiota-gut-brain axis was conducted. Clinical and preclinical studies evaluating the effectiveness of probiotic therapy in selected neurodegenerative diseases were analyzed. Results: Probiotic supplementation demonstrated beneficial effects across several neurodegenerative disorders. In AD, probiotics improved cognitive performance, reduced inflammatory markers, and attenuated oxidative stress. In PD, they alleviated gastrointestinal symptoms, improved bowel function, enhanced motor performance, and reduced systemic inflammation. In MS, probiotics decreased pro-inflammatory cytokine expression, promoted anti-inflammatory immune responses, and increased brain-derived neurotrophic factor levels. Experimental ALS studies indicated restoration of gut microbiota, improved intestinal barrier integrity, delayed disease progression, and prolonged survival in animal models. Conclusion: Probiotics demonstrate promising therapeutic potential in treating neurodegenerative diseases through modulation of gut microbiota and influence on the gut-brain axis. However, further clinical studies are necessary to confirm their clinical significance and biological effects.

Authors

Institutions

Publication Details

Journal
Journal of Education Health and Sport
Published
2026-11-16
DOI
https://doi.org/10.12775/jehs.2026.95.74001
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Probiotics in neurodegenerative disorders

Zenon Paweł Czuba, Łukasz Sędek, Małgorzata Katra, Rafał Szarek et al.
3 links
Journal of Education Health and Sport
Probiotics and Fermented Foods
article

Probiotics in neurodegenerative disorders

Zenon Paweł Czuba, Łukasz Sędek, Małgorzata Katra, Rafał Szarek, Mikołaj Szczęsny, Bogumiła Szarek
article en

Abstract

Background:Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS), are associated with chronic neuroinflammation and gut microbiota dysbiosis. Increasing evidence suggests that modulation of the microbiota–gut–brain axis with probiotics may represent a novel therapeutic strategy. Aim:To summarize current evidence on the effects of probiotic supplementation in AD, PD, MS, and ALS, focusing on potential mechanisms of action and therapeutic outcomes. Material and methods: A review of scientific literature concerning the influence of gut microbiota on the nervous system through the microbiota-gut-brain axis was conducted. Clinical and preclinical studies evaluating the effectiveness of probiotic therapy in selected neurodegenerative diseases were analyzed. Results: Probiotic supplementation demonstrated beneficial effects across several neurodegenerative disorders. In AD, probiotics improved cognitive performance, reduced inflammatory markers, and attenuated oxidative stress. In PD, they alleviated gastrointestinal symptoms, improved bowel function, enhanced motor performance, and reduced systemic inflammation. In MS, probiotics decreased pro-inflammatory cytokine expression, promoted anti-inflammatory immune responses, and increased brain-derived neurotrophic factor levels. Experimental ALS studies indicated restoration of gut microbiota, improved intestinal barrier integrity, delayed disease progression, and prolonged survival in animal models. Conclusion: Probiotics demonstrate promising therapeutic potential in treating neurodegenerative diseases through modulation of gut microbiota and influence on the gut-brain axis. However, further clinical studies are necessary to confirm their clinical significance and biological effects.

Journal of Education Health and SportVol. 95
Medical University of Silesia (PL), Independent Public Health Care Institution of the Ministry of the Interior and Administration in Krakow, Kraków, Poland (PL), Szpital Zakonu Bonifratrów św. Jana Grandego w Krakowie (PL)
Good health and well-being
Probiotics and Fermented Foods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon